Oral herbal therapies for treating osteoarthritis

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 5, 2014, Pages

  Cameron, Melainie ^a   Chrubasik, Sigrun ^b  

^a UNIVERSITY OF THE SUNSHINE COAST   (Australia)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPINIA GALANGA EXTRACT; AYURVEDIC DRUG; BOSWELLIA CARTERI EXTRACT; BOSWELLIA SERRATA EXTRACT; CELECOXIB; CURCUMA LONGA EXTRACT; DERRIS SCANDENS EXTRACT; DIACEREIN; DICLOFENAC; GINGER EXTRACT; GLUCOSAMINE SULFATE; HARPAGOPHYTUM PROCUMBENS EXTRACT; HERBACEOUS AGENT; IBUPROFEN; LEPIDIUM MEYENII EXTRACT; LOXOPROFEN; NAPROXEN; PERSEA GRATISSMA EXTRACT; PETIVERIA ALLIACEA EXTRACT; PYCNOGENOL; ROSA CANINA EXTRACT; SALIX PURPUREA EXTRACT; SOYBEAN EXTRACT; UNCARIA GUIANENSIS EXTRACT; UNCLASSIFIED DRUG; VALDECOXIB; ALPHA TOCOPHEROL; DRUG COMBINATION; PHYTOSTEROL; PIASCLEDINE; PLANT EXTRACT;

ARTICLE; COMPARATIVE EFFECTIVENESS; HERB; HUMAN; NONHUMAN; OSTEOARTHRITIS; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT OUTCOME; VISUAL ANALOG SCALE; WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX; BOSWELLIA; CHRONIC DISEASE; DRUG COMBINATION; META ANALYSIS; ORAL DRUG ADMINISTRATION; PHYTOTHERAPY; PROCEDURES;

ADMINISTRATION, ORAL; BOSWELLIA; CHRONIC DISEASE; DRUG COMBINATIONS; HUMANS; OSTEOARTHRITIS; PHYTOSTEROLS; PHYTOTHERAPY; PLANT EXTRACTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN E;

EID: 84977980819     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD002947.pub2     Document Type: Article

References (170)

1. Adegbehingbe OO, Adesanya SA, Idowu TO, Okimi OC, Oyelami OA, Iwalewa EO, et al. Clinical effects of Garcinia kola in knee osteoarthritis. Journal of Orthopedic Surgery 2008;3:34.
2. Altman RD, Marcussen KC. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis & Rheumatism 2001;44(11):2531-8.
3. Appelboom T, Schuermans J, Verbruggen G, Henrotin Y, Reginster JY. Symptoms modifying effect of avocado/ soyabean unsaponifiables (ASU) in knee osteoarthritis: A double-blind, prospective, placebo-controlled study. Scandinavian Journal of Rheumatology 2001;30(4):242-7.
4. Badria FA, El-Farahaty T, Shabana AA, Hawas SA, El- Batoty MF. Boswellia-curcumin preparation for treating knee osteoarthritis: A clinical evaluation. Alternative & Complementary Therapies 2002;8(6):341-8.
5. Belcaro G, Cesarone MR, Errichi S, Zulli C, Errichi BM, Vinciguerra G, et al. Treatment of osteoarthritis with Pycnogenol®. The SVOS (San Valentino Osteoarthritis Study). Evaluation of signs, symptoms, physical performance and vascular aspects. Phytotherapy Research 2008;22:518-23. [DOI: 10.1002/ptr.2376]
6. Bernhardt M, Keimel A, Belucci G, et al. Double-blind, randomised, comparative study of Phytodolor N and placebo as well as an open comparison with Felden 20 Tabs involving convalescent inpatients with arthrotic joint alterations. Unpublished Pharma Report 1991. [Steigrwald Pharmaceuticals, Germany]
7. Biegert C, Wagner I, Ludtke R, Kotter I, Lohmuller C, Gunaydin I, et al. Efficacy and safety of willow bark extract in the treatment of osteoarthritis and rheumatoid arthritis: Results of 2 randomized double-blind controlled trials. The Journal of Rheumatology 2004;31(11):2121-30.
8. Biller A. Results of two randomized controlled studies and of a post-marketing surveillance study investigating a Devil's claw extract [Ergebnisse zweier randomisierter kontrollierter Studien und einer Anwendungsbeobachtung mit Teufelskrallenextrakt]. In: Schulz V, Rietbrock N, Roots I, Loew D editor(s). In: Phylopharmaka VII. Darmstadt: Steinkopf-Verlag, 2002:81-92.
9. Bliddal H, Rosetzsky A, Schlichting P, Weidner MS, Andersen LA, Ibfelt HH, et al. A randomized, placebocontrolled, cross-over study of ginger extracts and ibuprofen in osteoarthritis. Osteoarthritis and Cartilage 2000;8:9-12.
10. Blotman F, Maheu E, Wulwik A, Caspard H, Lopez A. Efficacy and safety of avocado/soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip [Efficacite et tolerance des insaponifiables d'avocat/soja dans le traitement de la gonarthrose et de la coxarthrose symptomatiques]. Revue du Rhumatisme [éd Fr Joint Bone Spine] 1997;64(12):825-34.
11. Cao Y, Shi Y, Zheng Y, Shi M, Lo SK. Blood-nourishing and hard-softening capsule costs less in the management of osteoarthritis knee pain: A randomized controlled trial. eCAM 2005;2(3):363-8.
12. Cheras PA, Myers SP, Paul-Brent P, Outerbridge KH, Nielsen GVL. Randomised double-blind placebo-controlled trial on the potential modes of action of SheaFlex70 in osteoarthritis. Phytotherapy Research 2010;24:1126-31. [DOI: 10.1002/ptr.3075]
13. Chopra A, Lavin P, Patwardhan B, Chitre D. A 32-week randomized, placebo-controlled clinical evaluation of RA- 11, an Ayurvedic drug, on osteoarthritis of the knees. Journal of Clinical Rheumatology 2004;10(5):236-45.
14. Chopra A, SalujaM, Tillu G, Venugopalan A, Sarmukaddam S, Raut AK, et al. A randomized controlled exploratory evaluation of standardized Ayurvedic formulations in symptomatic osteoarthritis knees: A Government of India NMITLI project. Evidence-based Complementary and Alternative Medicine 2011;8:1-12. [DOI: 10.1155/2011/ 724291]
15. Chopra A, Saluja M, Tillu G, Sarmukkaddam S, Venugopalan A, Narsimulu G, Handa R, et al. Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence trial. Rheumatology 2013;52(8):1408-17. [DOI: 10.1093/rheumatology/kes414]
16. Cisár P, Jány R, Waczulíková I, Sumegová K, Muchová J, VojtaSSák J, et al. Effect of pine bark extract (Pycnogenol®) on symptoms of knee osteoarthritis. Phytotherapy Research 2008;22:1087-92. [DOI: 10.1002/ptr.2461]
17. Farid R, Mirfeizi Z, Mirheidari M, Rezaieyazdi Z, Mansouri H, Esmaelli H, et al. Pycnogenol supplementation reduces pain and stiffness and improved physical function in adults with knee osteoarthritis. Nutrition Research 2007;27:692-7. [DOI: 10.1016/j.nutres.2007.09.007]
18. FerrazMB, Pereira RB, Iwata NM, Atra E. Tipi. A popular analgesic tea: A double-blind cross-over trial in osteoarthritis (letter). Clinical and Experimental Rheumatology 1991;9: 205-12.
19. Frerick H, Biller A, Schmidt U. A treatment schedule for coxarthrosis: A double-blind study with Devil's claw [Stufenschema bei coxarthrose: Doppelblindstudie mit Teufelskralle]. Der Kassenarzt 2001;5:34-41.
20. Gupta AK, Acharya K, Sancheti PS, Joshi RS. A doubleblind, randomized, multicentric, placebo-controlled clinical trial of Antarth, a phytomedicine, in the treatment of osteoarthritis. Indian Journal of Pharmacology 2011;43: 69-72. [DOI: 10.4103/0253-7613.75674]
21. Huber B. Therapy of degenerative rheumatic diseases: Use of analgesic medication with Phytodolor N [Therapie degenerativer rheumatischer erkrankungen: Bedarf an zusatzlicher analgetischer medikation unter Phytodolor N]. Fortschritte der Medizin 1991;109:248-50.
22. Jung YB, Roh KJ, Jung JA, Jung K, Yoo H, Cho YB, et al. Effect of SKI306X, a new herbal anti-arthritic agent, in patients with osteoarthritis if the knee: A double-blind placebo controlled study. American Journal of Chinese Medicine 2001;29(3-4):485-91.
23. Jung YB, Seong SC, Lee MC, Shin YU, Kim DH, Kim JM, et al. A four-week randomized, double-blind trial of the efficacy and safety of SKI306X: A herbal anti-arthritic agent versus diclofenac in osteoarthritis of the knee. American Journal of Chinese Medicine 2004;32(2):291-301.
24. Kimmatkar N, Thawani V, Hingorani L, Khiyani R. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee - A randomized double blind placebo controlled trial. Phytomedicine 2003;10:3-7.
25. Kuptniratsaikul V, Thanakhumtorn S, et al. Efficacy and safety of Curcumica domestica extracts in patients with knee osteoarthritis. Journal of Alternative and Complementary Medicine 2009;15:891-7. [DOI: 10.1089/acm.2008.0186]
26. Kuptniratsaikul V, Pinthong T, Bunjob M, Thanakhumtorn S, Chinswangwatanakul P, Thamlikitkul V. Efficacy and safety of Derris scandens benth extracts in patients with knee osteoarthritis. Journal of Alternative and ComplementaryMedicine 2011;17:147-53. [DOI: 10.1089/ acm.2010.0213]
27. Leblan D, Chantre P, Fournié B. Harpogophytum procumbens in the treatment of knee and hip osteoarthritis: Fourmonth results of a prospective, multicenter, double-blind trial versus diacerhein [L'harpagophyton dans le traitement de la gonarthrose et de la coxarthrose. Résultats à quatre mois d'une étude prospective multicentrique, contrôlée en double aveugle, versus diacerhéine]. Revue du Rhumatisme [éd Fr Joint Bone Spine] 2000;67(5):462-7.
28. Lequesne M, Maheu E, Cadet C, Dreiser RL. Structural effect of avocado/soyabean unsaponifiables on joint space loss in osteoarthritis of the hip. Arthritis Care & Research 2002;47:50-8.
29. Maheu E, Mazieres B, Valat J-P, Loyau G, Le Loet X, Bourgeois P, et al. Symptomatic efficacy of avocado/soybean unsaponifiables in the treatment of osteoarthritis of the knee and hip. Arthritis & Rheumatism 1998;41(1):81-91.
30. Maheu E, Cadet C, Marty M, Moyse D, Kerloch I, Coste P, Dougados M, Mazières B, Spector TD, Halhol H, Grouin JM, Lequesne M. Randomised, controlled trial of avocadosoybean unsaponifiable (Piascledine) effect on structure modification in hip osteoarthritis: the ERADIAS study. Annals of the Rheumatic Diseases 2013;Jan 23:[Epub ahead of print]. [DOI: 10.1136/annrheumdis-2012-202485]
31. Majima T, Inoue M, Kasahara Y, Onodera T, Takahashi D, Minami A. Effect of the Japanese herbal medicine, Boiogito, on the osteoarthritis of the knee with jointeffusion. Sports Medicine, Arthroscopy, Rehabilitation, Therapy & Technology 2012;4:3. [DOI: 10.1186/1758-2555-4-3]
32. Medhi B, Kishore K, Singh U, Seth SD. Comparative clinical trial of castor oil and diclofenac sodium in patients with osteoarthritis. Phytotherapy Research 2009;23: 1469-73. [DOI: 10.1002/ptr.2804]
33. Mehta K, Gala J, Bhasale S, Naik S, Modak M, Thakur H, et al. Comparison of glucosamine sulfate and a polyherbal supplement for the relief of osteoarthritis of the knee: a randomized controlled trial [ISRCTN25438351]. BMC Complementary and Alternative Medicine 2007;7:34. [DOI: 10.1186/1472-6882-7-34]
34. Mills SY, Jacoby RK, Chacksfield M, Willoughby M. Effect of a proprietary herbal medicine on the relief of chronic arthritic pain: A double-blind study. British Journal of Rheumatology 1996;35:874-8.
35. Oben J, Enonchong E, Kothari S, Chambliss W, Garrison R, Dolnick D. Phellodendron and citrus extracts benefit joint health in osteoarthritis patients: a pilot, double-blind, placebo-controlled study. Nutrition Journal 2009;8:38. [DOI: 10.1186/1475-2891-8-38]
36. Pavelka K, Coste P, Géher P, Krejci G. Efficacy and safety of piascledine 300 versus chondroitin sulfate in a 6 months treatment plus 2 months observation in patients with osteoarthritis of the knee. Clinical Rheumatology 2010;29: 659-70. [DOI: 10.1007/s10067-010-1384-8]
37. Piscoya J, Rodriguez Z, Bustamante SA, Okuhama NN, Miller MJS, Sandoval M. Efficacy and safety of freeze-dried cat's claw in osteoarthritis of the knee: Mechanism of action of the species Uncaria guianensis. Inflammation Research 2001;50:442-8.
38. Rein E, Kharazami A, Winther K. A herbal remedy, Hyben Vital (stand. powder of a subspecies of Rosa canina fruits), reduces pain and improves general wellbeing in patients with osteoarthritis - a double-blind, placebo-controlled, randomised trial. Phytomedicine 2004;11:383-91.
39. Schadler W. Phytodolor for the treatment of activated arthrosis. Rheuma 1988;8:288-90.
40. Schmelz H, Hammerle HD, Springorum HW. Analgesic effect of a Devil's claw extract in various chronic degenerative joint diseases [Analgetische Wirkung eines Teufelskrallenwurzel-Extraktes bei verschiedenen chronisch-degenerativen Gelenkerkrankungen]. In: Chrubasik S, Wink M editor(s). Rheumatherapie mit Phytopharmaka. Stuttgart: Hippokrates Verlag, 1997:86-9.
41. Schmid B, Ludtke R, Selbmann HK, Kotter I, Tschirdewahn B, Schaffner W, et al. Efficacy and tolerability of a standardized willow bark extract in patients with osteoarthritis: Randomized placebo-controlled double blind clinical trial [Wirksamkeit und vertraglichkeit eines standardisierten weidenrindenextraktes bei arthose-patienten: Randomisierte, placebo-kontrollierte doppelblindstudie]. Zeitschrift für Rheumatologie 2000;59: 1-7.
42. Sengupta K, Alluri KV, Satish AR, Mishra S, Golakoti T, Sarma KVS, et al. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin® for treatment of osteoarthritis of the knee. Arthritis Research & Therapy 2008;10:R85. [DOI: 10.1186/ar2461]
43. Sengupta K, Krishnaraju AV, Vishal AA, Mishra A, Trimurtulu G, Sarma KVS, et al. Comparative efficacy and tolerability of 5-Loxin® and Aflapin® against osteoarthritis of the knee: A double blind, randomized, placebo controlled clinical study. International Journal of Medical Sciences 2010; 7(6):366-77.
44. Sontakke S, Thawani V, Pimpalkhute S, Kambra P, Babhulkar S, Hingorani L. Open, randomized, controlled trial of Boswellia serrata extract as compared to valdecoxib in osteoarthritis of knee. Indian Journal of Pharmacology 2007; 39:27-9.
45. Teekachunhatean S, Kunanusom P, Rojanasthien N, Sananpanich K, Pojchamarnwitputh S, Lheiochaiphunt S, Pruksakorn S. Chinese herbal recipe versus diclofenac in symptomatic treatment of osteoarthritis of the knee: A randomized controlled trial. BMC Comlementary and Alternative Medicine 2004;4:19. [DOI: 10.1186/ 1472-6882-4-19]
46. Vishal AA, Mishra A, Raychaudhuri SP. A double blind, randomized, placebo controlled clinical study evaluates the early efficacy of Aflapin® in subjects with osteoarthritis of the knee. International Journal of Medical Sciences 2011;8 (7):615-22.
47. Warholm O, Skaar S, Hedman E, Molmen HM, Eik L. The effects of a standardized herbal remedy made from a subtype of Rosa canina in patients with osteoarthritis: A double-blind, randomized, placebo-controlled clinical trial. Current Therapeutic Research 2003;64(1):21-31.
48. Wigler I, Grotto I, Caspi D, Yaron M. The effects of Zintona EC (a ginger extract) on symptomatic gonarthritis. Osteoarthritis and Cartilage 2003;11:783-9.
49. Winther K, Apel K, Thamsborg G. A powder made from seeds and shells of a rose-hip subspecies (Rosa canina) reduces symptoms of knee and hip osteoarthritis: A randomized, double-blind, placebo-controlled clinical trial. Scandinavian Journal of Rheumatology 2005;34:302-8.
50. Anonymous. The garlic treatment: detoxifying with garlic. [Die knoblauchkur: entschlackung durch knoblauch]. Natur & Heilen 1993;70(10):520-1.
51. Belcaro G, Cesarone MR, Dugall M, Pellegrini L, Ledda A, Grossi MG, et al. Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Alternative Medicine Review 2010;15(4):337-44.
52. Biswas NR, Biswas A, Pandey RM. EASE - a herbal preparation for rheumatoid arthritis, non specific arthritis and osteoarthritis. FACT: Focus on Alternative and Complementary Therapies. Proceedings of 4th Annual Symposium on Complementary Health Care. Exeter (UK), 1997; Vol. 2, issue 4:186-7.
53. Biswas NR, Biswas K, Pandey M, Pandy RM. Treatment of osteoarthritis, rheumatoid arthritis and non-specific arthritis with a herbal drug: a double-blind, active drug controlled parallel study. JK Practitioner 1998;5(2):129-32.
54. Brien S, Lewith GT, McGregor G. Devil's Claw (Harpagophytum procumbens) as a treatment for osteoarthritis: A review of safety and efficacy. The Journal of Alternative and Complementary Medicine 2006;12:981-93.
55. Chantre P, Cappelaere A, Leblan D, Guedon D, Vandermander J, Fournie B. Efficacy and tolerance of Harpagophytum procumbens versus diacerhein in treatment of osteoarthritis. Phytomedicine 2000;7(3):177-83.
56. Chrubasik S, Wink M. Traditional herbal therapy for the treatment of rheumatic pain: Preparations from Devil's claw and stinging nettle. Pain Digest 1998;8:94-101.
57. Dharmananda S. Chinese herbal therapies for chronic joint pain. The American Chiropractor 1985;January: 38-42.
58. Du T-X, Han X-F, Gao S-T. Effect of hanshibi granule on rheumatism due to blockage of cold and damp. Chinese Journal of Clinical Rehabilitation 2006;10:148-50.
59. Falch VB. Ginger - not only a spice. Review of its effect and efficacy profile [Ingwer - nicht nur ein Gewurz. Untersuchungen zu Wirkungen und Wirksamkeit]. Deutsche Apotheker Zeitung 1997;137:47-52, 55-60.
60. Fang R, Meng Q-C, Deng Y-J, Song G, Bai Y-P. Effects of Bu Shen Tong Luo decoction on matrix metalloproteinase- 1, matrix metalloproteinase-3, tissue inhibitor of matrix metalloprotease-1 and interleukin-1beta content in the synovial fluid and serum of patients with knee osteoarthritis. Journal of Clinical Rehabilitative Tissue Engineering Research 2008;12:5581-5.
61. Gendo U. Chronische Polyarthritis in view of traditional Chinese medicine (TCM) [Die chronische Polyarthritis aus der Sicht der traditionellen Chinesischen Medizin (TCM)]. Naturamed 1997;12(10):37-40.
62. Grahame R, Robinson BV. Devil's claw (Harpagophytum procumbens): Pharmacological and clinical studies. Annals of the Rheumatic Diseases 1981;40:632.
63. Guyader M. Herbal anti-rheumatic therapies: A longitudinal, pharmacological and clinical study of the treatment of 50 osteoarthritic patients with Harpagophytum procumbens (Devil's Claw) following hospital intervention [Les plantes anti-rhumatismales. Etude historique et pharmacologique, et etude clinique du nebulisat d'harpagophytum procumbens D.C. chez 50 patients arthrosiques suivis en service hospitalier]. Thesis for the award of the degree Doctor of Medicine. 1984.
64. Hamblin L, Laird A, Parkes E, Walker AF. Improved arthritic knee health in a pilot RCT of phytotherapy. The Journal of the Royal Society for the Promotion of Health 2008; 128(5):255-62. [CENTRAL: 00651201]
65. Jacquet A, Girodet P, Pariente A, Forest K, Mallet, Moore N. Phytalgic, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised doubleblind placebo-controlled clinical trial. Arthritis Research & Therapy 2009;11:R192. [DOI: 10.1186/ar2891]
66. Kogure T, Tatsumi T, Shigeta T, Fujinaga H, Sato T, Niizawa A. Effect of Kampo medicine on pain and range of motion of osteoarthritis of the hip accompanied by acetabular dysplasia: Case report and literature review. Integrative Medicine Highlights 2011;6:13-7. [DOI: 10.4137/IMI.S7884]
67. Kielczynski W. Osteoarthritis - clinical outcomes after uniform, long-term herbal treatment. The European Journal of Herbal Medicine 1997;3(2):29-35.
68. Kulkarni RR, Patki PS, Jog VP, Gandage SG, Patwardhan B. Treatment of osteoarthritis with a herbomineral formulation: A double-blind, placebo-controlled, cross-over study. Journal of Ethnopharmacology 1991;33:91-5.
69. Lechner M, Steirer I, Brinkhaus B, Chen Y, Krist-Dungl C, Koschier A, et al. Efficacy of individualized Chinese herbal medication in osteoarthrosis of hip and knee: a double-blind, randomized-controlled clinical study. Journal of Alternative and Complementary Medicine 2011;17(6): 539-47.
70. Levy RM, Saikovsky R, Shmidt E, Khokhlov A, Burnett BP. Flavocoxid is as effective as naproxen for managing the signs and symptoms of osteoarthritis of the knee in humans: a short-term randomized, double-blind pilot study. Nutrition Research 2009;29:298-304.
71. Linsheng W. Treatment of bony arthritis with herbal medicine and by massotherapy - analysis of 121 cases. Journal of Traditional Chinese Medicine 1997;17(1):32-6.
72. Loew D, Schuster O, Mollerfeld J. Stability and biopharmaceutical quality. A postulate for bioavailability and effectiveness of Harpagophytum procumbens [Stabilitat und biopharmazeutische Qualitat. Voraussetzung fur Bioverfugbarkeit und Wirksamkeit von Harpagophytum procumbens]. In: Loew D, Rietcrock N editor(s). Phytopharmaka II. Forschung und klinische Anwendung. Darmstadt: Steinkopf-Verlag, 1996:83-93.
73. Long L, Soeken K, Ernst E. Herbal medicines for the treatment of osteoarthritis: A systematic review. Rheumatology 2001;40:779-93.
74. Lung YB, Seong SC, Lee MC, Shin YU, Kim DH, Kim JM, et al. A four-week, randomized, double-blind trial of the efficacy and safety of SKI306X: a herbal anti-arthritic agent versus diclofenac in osteoarthritis of the knee. The American Journal of Chinese Medicine 2004;32:291-301.
75. Mishra LC, Singh BB, Vinjamury SP. The effectiveness of Commiphora mukul for osteoarthritis of the knee: an outcomes study. Althernative Therapies in Health and Medicine 2003;9:74-9.
76. Myers S, O'Connor J, Fitton JH, Brooks L, Rolfe M, Connellan P, et al. A combined phase I and phase II open label study on the effects of a seaweed extract nutrient complex on osteoarthritis. Biologics: Targets & Therapy 2010;4:33-44.
77. Park SH, Kim SK, et al. Effects of AIF on knee osteoarthritis patients: Double-blind, randomized, placebo-controlled study. Korean Journal of Physiology and Pharmacology 2009; 13:33-7.
78. Rein E, Kharazmi A, Thamsborg G, Winther K. A herbal remedy, made from a subspecies of rose-hip Rosa canina, reduces symptoms of knee and hip osteoarthritis. Osteoarthritis and Cartilage 2004;12 Suppl 2:S80.
79. Ruess D. Echinacin in the treatment of primary chronic polyarthritis [Echinacin in der Therapie der primar-chronischen Polyarthritis]. ZFA - Stuttgart 1981;57 (11):865.
80. Rosen PD, Liakeas GP, Sadigim E, Bied AM. A pilot study assessing the short term use of Tanacetum parthenium for treatment of osteoarthritis. Integrative Medicine 2013;12 (3):31-6.
81. Sagar VMV. A clinical study of Amavata with special reference to some indigenous drugs. Rheumatism 1988-89; 24(3):3-7.
82. Saley SR, Tilak MN, Deshmukh SS. Amavata - a clinical study of 41 cases. Rheumatism 1987;22(2):46-50.
83. Schaffner W. Willow bark - an antirheumatic in modern phytotherapy? [Weidenrinde - Ein Antirheumatikum der modernen Phytotherapie?]. In: Chrubasik S, Wink M editor(s). Rheumatherapie mit Phytopharmaka. Stuttgart: Hippokrates Verglag, 1997:125-7.
84. Schmid B, Tschirdewahn B, Kotter I, Gunaydin I, Ludtke R, Selbmann HK, et al. Analgesic effects of willow bark extract in osteoarthritis: results of a clinical doubleblind trial. FACT:Focus on Alternative and Complementary Therapies 1998;3(4):186.
85. Schmid B, Lüdtke R, Selbmann H-K, Kötter I, Tschirdewahn B, Schaffner W, Heide L. Efficacy and tolerability of a standardized willow bark extract in patients with osteoarthritis: Randomized placebo-controlled double blind clinical trial. Phytotherapy Research 2001;15:344-50. [DOI: 10.1002/ptr.981]
86. Srivastava KC, Mustafa T. Ginger (Zingiber officinale) and rheumatic disorders. Medical Hypotheses 1989;29:25-8.
87. Wang ZM, Chang JY, et al. A report on 310 cases of articular rheumatism treated with Feng Shi Han Tong tablet. Chung Hsi I Chieh Ho Tsa Chih 1985;5(5):284-5, 260.
88. Wegener T, Lupke NP. Treatment of patients with arthrosis of hip or knee with an aqueous extract of Devil's claw (Harpagophytum procumbens DC). Phytotherapy Research 2003;17(10):1165-72.
89. Winther K, Kharazmi A, Rein E. A powder made from a subspecies of rosehip (Rosa canina) reduces WOMAC symptoms scores as well as cholesterol levels in patients suffering from osteoarthritis. Osteoarthritis and Cartilage 2004;13 Suppl A:S93.
90. Xu J-W, Ding J-X. An analysis on the clinical therapeutic effect of the manipulation matched with Chinese medical herb washing for treatment of osteoarthritis of the knee. Journal of Beijing Teachers College of Physical Education 2005;1:9.
91. Yuelong C, Hongsheng Z, Jian P, Feiyue L, Shaojian X, Jinghua G, et al. Individually integrated traditional Chinese medicine approach in the management of knee osteoarthritis: study protocol for a randomized controlled trial. Trials 2011;12:160. [DOI: 10.1186/ 1745-6215-12-160]
92. Zell J, Ecker R, Batz H, Vestweber AM. Mistletoe for hip and knee arthrosis: Segment - or immunotherapy? [Misteltherapie bei Gon- und Coxarthrose: Segment - oder Immuntherapie? Eine Pilotstudie]. Heilkunst 1993;106(9): 23-6.
93. Zeng Y-R, Fan Y-G, Wu F, Li X-P, Fan H-J. Effects of compound herb of invigorating kidney and promoting blood flow on serum matrix metalloproteinases-3, tumor necrosis factor alpha, interleukin-1, hyaluronic acid, lipid peroxidation levels and superoxide dismutase activity in patients with knee osteoarthritis. Journal of Clinical Rehabilitative Tissue Engineering Research 2008;12:5436-9. References to studies awaiting assessment
94. Gao G, Wu H, Tian J, Du J, Xie X, Gao J. Clinical efficacy of bushen huoxue qubi decoction on treatment of knee-osteoarthritis and its effect on hemarheology, antiinflammation and antioxidation. Zhongguo Zhong Yao Za Zhi 2012;37(3):390-6.
95. Hochberg MC, Lao LX, Langenberg P, Fong HHS, Lee DYW, Berman B. Efficacy and Safety of the Chinese Herbal Compound Hou-Lou-Xiao-Ling Dan in Patients with Osteoarthritis of the Knee: Results of a Phase II International Study [Abstract]. Arthritis and Rheumatism 2012;64(10):S112. [DOI: 10.1002/art.37993]
96. Kang XZ, Wu QF, Jie HY. Clinical study on the treatment of knee osteoarthritis by wangbi tablet. Zhongguo Zhong Xi Yi Jie He Za Zhi [Chinese Journal of integrated Traditional and Western Medicine] 2011;31(9):1205-8.
97. Liu H-B, Zhang J-F, Zhong L-W, Yang H. Manipulation plus pyrola compound traditional Chinese medicine in treatment of senile osteoarthritis of knee. Chinese Journal of Clinical Rehabilitation 2006;10(23):30-2. [CENTRAL: 00613036]
98. Pinsornsak P, Niempoog S. The efficacy of Curcuma longa L. extract as an adjuvant therapy in primary knee osteoarthritis: A randomized controlled trial. Journal of the Medical Association of Thailand 2012;95 Suppl 1:S51-8.
99. Tao QW, Xu Y, Jin DE, Yan XP. Clinical efficacy and safety of Gubitong Recipe () in treating osteoarthritis of knee joint. Chinese Journal of Integrative Medicine 2009;15(6): 458-61.
100. Zhong Q-S, Ye G-H, Wang H-Z, Lin S-H. Treatment of knee osteoarthritis by invigorating the kidney, dispelling the cold and activating the collaterals: A randomized controlled study. Chinese Journal of Clinical Rehabilitation 2006;10: 177-9.
101. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. The American College of Rheumatology crtieria for the classification and reporting of osteoarthritis of the knee. Arthritis & Rheumatism 1986;29:1039-49.
102. Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D, Brandt K. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis & Rheumatism 1990;33:1601-10.
103. Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D, Brandt K, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis & Rheumatism 1991;34:505-14.
104. Basch E, Boon H, Davies-Heerema T, Foppo I, Hashmi S, Hasskarl J, et al. Boswellia: an evidence-based systematic review by the Natural Standard Research Collaboration. Journal of Herbal Pharmacotherapy 2004;4(3):63-83.
105. Begg C, Cho M, Eastwood S, Horeton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT Statement. JAMA 1996; 276(8):637-9.
106. Blumenthal M. The complete German Commission E Monographs. Austin, TX: American Botanical Council, 1998.
107. Boullata JI, McDonnell PJ, Oliva CD. Anaphylactic reaction to a dietary supplement containing willow bark. Annals of Pharmacotherapy 2003;37:832-5.
108. Cameron M, Gagnier JJ, Chrubasik S. Herbal therapy for treating rheumatoid arthritis. Cochrane Database of Systematic Reviews 2011, Issue 2. [DOI: 10.1002/ 14651858.CD002948]
109. Cameron M, Chrubasik S. Topical herbal therapies for treating osteoarthritis. Cochrane Database of Systematic Reviews 2013, Issue 5. [DOI: 10.1002/ 14651858.CD010538]
110. Cates CD. Visual Rx NNT Calculator. Dr Chris Cates EBM website. Available from http://www.nntonline.net/, 2008.
111. Choi JH, Choi JH, Kim DY, Yoon JH, Youn HY, Yi JB, et al. Effects of SKI 306X, a new herbal agent, on proteoglycan degradation in cartilage explant culture and collagenaseinduced rabbit osteoarthritis model. Osteoarthritis and Cartilage 2002;10:471-8.
112. Christensen R, Bartels EM, Astrup A, Bliddal H. Symptomatic efficacy of avocado-soybean unsaponifiables (ASU) in osteoarthritis (OA) patients: a meta-analysis of randomized controlled trials. Osteoarthritis and Cartilage 2008;16:399-408.
113. Christensen R, Bartels EM, Altman RD, Astrup A, Bliddal H. Does the hip powder of Rosa canina (rosehip) reduce pain in osteoarthritis patients? A meta-analysis of randomized controlled trials. Osteoarthritis and Cartilage 2008;16: 965-72.
114. Chrubasik S, Sporer F, Wink M. Active ingredients in medicines from Harpagophytum procumbens [Zum Wirkstoffgehalt in Arzneimitteln aus Harpagophytum procumbens]. Forschende Komplementarmedizin 1996;3: 57-63.
115. Chrubasik S, Junck H, Breitschwerdt H, Conradt C, Zappe H. Effectiveness of Harpagophytum extract WS 1531 in the treatment of exacerbation of low back pain: A randomized, placebo-controlled, double-blind study. European Journal of Anaesthesiology 1999;16:118-29.
116. Chrubasik S, Eisenberg E, Balan E, Weinberger T, Luzzati R, Conradt C. Treatment of low back pain exacerbations with willow bark extract: A randomized double-blind study. American Journal of Medicine 2000;109:9-14.
117. Chrubasik S, Künzel O, Model A, Conradt C, Black A. Treatment of low back pain with a herbal or syntheticantirheumatic: a randomized controlled study. Rheumatology 2001;40:1388-93.
118. Chrubasik S, Fiebich B, Black A, Pollak S. Treating low back pain with an extract of Harpagophytum that inhibits cytokine release. European Journal of Anaesthesiology 2002; 19:209.
119. Chrubasik S, Roufogalis B. Bioequivalence of herbal medicines. New Zealand Journal of Pharmacy 2003;53: 39-44.
120. Chrubasik S, Pittler MH, Roufogalis BD. Zingiberis rhizoma: a comprehensive review on the ginger effect and efficacy profiles. Phytomedicine 2005;12(9):684-701.
121. Chrubasik JE, Lindhorst E, Neumann E, Gerlach U, Faller- Marquardt M, Torda T, Muller-Ladner U, Chrubasik S. Potential molecular basis of the chondroprotective effect of Harpagophytum procumbens. Phytomedicine 2006;13: 598-600.
122. Chrubasik JE, Roufogalis BD, Chrubasik S. Evidence of effectiveness of herbal anti-inflammatory drugs in the treatment of painful osteoarthritis including chronic low back pain. Phytotherapy Research 2007;21:675-83.
123. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors).Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011) The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
124. European Medicines Agency (EMA). Assessment report on salicis cortex (willow bark) and herbal preparation(s) thereof with well-established use and traditional use. EMA, London, 2009 2009.
125. European Scientific Cooperative on Phytotherapy (Eds). ESCOP Monographs. New York: Thieme-Verlag Stuttgart, 2003.
126. European Scientific Cooperative on Phytotherapy (Eds). ESCOP Monographs. Vol. Supplement, Stuttgart, New York: Thieme Press, 2009.
127. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Annals of Internal Medicine 1991;115:787-96.
128. Glinko A. Pharmacological properties of a standardized extract from Willow Bark (Cortex salicis) [treatise]. Chair of Pharmacology and Toxicology. Pomeranian Academy of Medicine. Szczecin, 1998.
129. Gundermann KJ. Phytodolor solution. Clinical expert report. Darmstadt, Germany: Steigerwald, 2001.
130. Hadzhiyski H, Lindhorst E, Raif W, Torda T, Chrubasik S. Impact of Harpagophytum procumbens on the urinary pyridinoline deoxypyridinoline ratio in experimental osteoarthritis [Abstract]. FACT: Focus on Alternative and Complementary Therapies 2006;11:13.
131. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. Higgins JPT, Green S (editors). The Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org, 2011.
132. ICH. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Synopsis of ICH guidelines and topics. Geneva, Switzerland: Author, 2004.
133. Jäger AK, Eldeen IM, van Staden J. COX-1 and -2 activity of rose hip. Phytotherapy Research 2007;21(12):1251-2.
134. Jäger AK, Petersen KN, Thomasen G, Christensen SB. Isolation of linoleic and alpha-linolenic acids as COX-1 and -2 inhibitors in rose hip. Phytotherapy Research 2008;22(7): 982-4.
135. Krishnaraju AV, Sundararaju D, Vamsikrishna U, Suryachandra R, Machiraju G, Sengupta K, Trimurtulu G. Safety and toxicological evaluation of Aflapin: a novel Boswellia-derived anti-inflammatory product. Toxicology Mechanisms and Methods 2010;20(9):556-63.
136. Krivoy N, Pavlotzky E, Chrubasik S, Eisenberg E, Brooks G. Effect of Salicis cortex extract on human platelet aggregation. Planta Medica 2001;67:209-13.
137. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis & Rheumatism 2008;58:26-35.
138. Lee YH, Woo JH, Choi SJ, Ji JD, Song GG. Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis. Rheumatology International 2010;30(3):357-63.
139. Malemud CJ. Anticytokine therapy for osteoarthritis: Evidence to date. Drugs & Aging 2010;27:95-115. [DOI: 10.2165/11319950-000000000-00000]
140. Mazieres B, Tempesta C, TiechardM, Vaguier G. Pathologic and biochemical effects of a lipidic avocado and soya extract on an experimental post-contusive model of OA [Abstract]. Osteoarthritis and Cartilage 1993;1:46.
141. Moher D, Schulz KF, Altman DG. The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials. Annals of Internal Medicine 2001;134:657-62.
142. Ofman JJ, MacLean CH, Straus WL, Morton SC, Berger ML, Roth EA, Shekelle P. A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs. Journal of Rheumatology 2002;29: 804-12.
143. Ofman JJ, Maclean CH, Straus WL, Morton SC, Berger ML, Roth EA, Shekelle PG. Meta-analysis of dyspepsia and nonsteroidal antiinflammatory drugs. Arthritis & Rheumatism 2003;49:508-18.
144. Olivier P, Montastruc JL. Réseau français des centres régionaux de pharmacovigilance [Post-marketing safety profile of avocado-soybean unsaponifiables]. Presse Medicale 2010;39(10):e211-6.
145. Pham T, Van Der Heijde D, Lassere M, Altman RD, Anderson JJ, Bellamy N, et al. Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteria. Journal of Rheumatology 2003;30: 1645-54.
146. Pham T, van der Heijde D, Altman RD, Anderson JJ, Bellamy N, Hochberg M, et al. OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis and Cartilage 2004;12:389-99.
147. Reginster JY, Malmstrom K, Mehta A, Bergman G, Ko AT, Curtis SP, Reicin AS. Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritis. Annals of the Rheumatic Diseases 2007;66:945-51.
148. Reichenbach S, Sterchi R, Scherer M, Trelle S, Bürgi E, Bürgi U, et al. Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Annals of Internal Medicine 2007;146 (8):580-90.
149. Sangha O. Epidemiology of rheumatic diseases. Rheumatology 2000;39 Suppl 2:3-12.
150. Schmid B. Treatment of hip and knee osteoarthritis with willow bark extract [Behandlung von Cox- und Gonarthrosen mit einem Weidenrindenextrakt]. Dissertation Universität Tübingen 1998.
151. Schmitz N, Kraus VB, Aigner T. Targets to tackle--the pathophysiology of the disease. Current Drug Targets 2010; 11:521-7.
152. Schoonees A, Visser J, Musekiwa A, Volmink J. Pycnogenol® (extract of French maritime pine bark) for the treatment of chronic disorders. Cochrane Database of Systematic Reviews 2012, Issue 4. [DOI: 10.1002/ 14651858.CD008294.pub4]
153. Schunemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration, updated March 2011.
154. Schunemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, Guyatt GH. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration, updated March 2011.
155. Smalley WE, Griffin MR, Fought RL, RayWA. Excess costs from gastrointestinal disease associated with nonsteroidal anti-inflammatory drugs. Journal of General Internal Medicine 1996;11:461-9.
156. Sporer F, Chrubasik S. Preparations from Devil's claw (Harpagophytum procumbens) [Präparate aus der Teufelskralle (Harpagophytum procumbens)]. Zeitschrift für Phytotherapie 1999;20:235-6.
157. Stohs SJ, Preuss HG, Shara M. The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid psynephrine. Phytotherapy Research 2011;25(10):1421-8. [DOI: 10.1002/ptr.3490]
158. Stone E. An account of the success of the bark of the willow in the cure of agues. Philosophy. Trans: Royal Society London 1763;53:195-200.
159. Valerio LG Jr, Gonzales GF. Toxicological aspects of the South American herbs cat's claw (Uncaria tomentosa) and Maca (Lepidium meyenii): a critical synopsis. Toxicology Review 2005;24(1):11-35.
160. van den Berg WB. Osteoarthritis year 2010 in review: Pathomechanisms. Osteoarthritis and Cartilage 2011;19: 338-41.
161. Vlachojannis JE, Roufogalis BD, Chrubasik S. Systematic review on the safety of Harpagophytum preparations for osteoarthritic and low back pain. Phytotherapy Research 2008;22(2):149-52. [DOI: 10.1002/ptr.2314]
162. Vlachojannis JE, Duke RK, Tran VH, Duke CC, Chrubasik S. Anti-inflammatory herbal medicines for the control of pain. In: Carpinella M C, Rai M editor(s). Novel Therapeutic Agents from Plants. Enfield, NH, USA: Science Publisher, 2009:339-67.
163. Vlachojannis C, Magora F, Chrubasik S. Pro and contra duration restriction of willow bark treatment. Phytotherapy Research 2014;28(1):148-9.
164. Wandel S, Jüni P, Tendal B, Nüesch E, Villiger PM,Welton NJ, Reichenbach S, Trelle S. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ 2010;341:c4675. [DOI: 10.1136/bmj.c4675]
165. Wenzig EM, Widowitz U, Kunert O, Chrubasik S, Bucar F, Knauder E, Bauer R. Phytochemical composition and in vitro pharmacological activity of two rose hip (Rosa canina L.) preparations. Phytomedicine 2008;15(10):826-35.
166. Zhang W, Doherty M, Leeb BF, Alekseeva L, Arden NK, Bijlsma JW, et al. EULAR evidence based recommendations for the diagnosis of hand osteoarthritis - report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Annals of Rheumatic Diseases 2009;68:8-17.
167. Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Clinical GeriatricMedicine 2010;26:355-69.
168. Zhang W, Doherty M, Peat G, Bierma-Zeinstra MA, Arden NK, Bresnihan B, et al. EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis. Annals of Rheumatic Diseases 2010;69(3):483-9. References to other published versions of this review
169. Cameron M, Chrubasik S, Parsons T, Gagnier J, Blümle A, Little C. Herbal therapy for treating osteoarthritis: Update of a Cochrane review. Annals of the Rheumatic Diseases 2007;66 Supp II:494.
170. Cameron M, Gagnier J, Little C, Parsons T, Blümle A, Chrubasik S. Evidence of the effectiveness of herbal medicinal products in the treatment of arthritis. Part A: Osteoathritis. Phytotherapy Research 2009;23:1497-515. [DOI: 10.1002/ptr.3007]